That's just the critical according to clinicaltria
Post# of 148179
Severe trial is: Leronlimab subcutaneously once a week (up to 4 doses) until hospital discharge. The first dose will be of 700 mg, followed by weekly doses of 350 mg.
I guess that could have changed since clinicaltrials.gov updated their site but that was what was originally announced.